Our areas of partnering expertise

We have four key areas of expertise

M&A and subsequent asset integration: Our experienced team ensures seamless processes from due diligence to signature and provides end-to-end integration support, delivering on time, on budget, and without disruption to patient care
R&D: We are always looking to strengthen our R&D pipeline through external innovation in pain and adjacent indications
Partner business: By working with partners worldwide, we expand access to our portfolio, reaching more people with the life-changing medicines they need
Contract manufacturing business: At Grünenthal, we offer full-service contract manufacturing and reliable supply for our partners. Our dedicated, flexible offerings are tailored to meet each partner’s specific needs.

Our focus areas

At the same time, we take a therapy-agnostic approach to M&A deals around established brands — seeking promising, established brands that diversify and strengthen our existing commercial portfolio while immediately increasing our profitability and cash flow.

In terms of R&D, we are focused on leveraging our deep scientific expertise in pain and its pathophysiology – neurobiology, including sensory biology, hypersensitivity, neuroinflammation, and neurodegeneration – to drive innovation across the field and into adjacent therapeutic areas.

What do we bring to the table?

Our broad experience means we can support products of all sizes – from small and mid-sized to complex – at all stages of the lifecycle. And with dedicated resources at every stage of the deal process — from initial scouting to post-integration support and constant partner management — we offer seamless, end-to-end partnership.

We don’t believe in a one-size-fits-all approach. Every product and geography is different, which is why we tailor distribution, marketing, and licensing strategies to fit the specific needs of each brand.

We’re proud of the strength and scale of our global network, with partnerships spanning over 100 countries. Thanks to our robust supply capabilities, we’ve maintained reliable product supply to patients at any time – from the COVID-19 pandemic through to today.

Who are we looking to collaborate with?

We’re always looking to collaborate with like-minded organisations – those that put patients first and uphold the same high ethical standards we hold ourselves to.

For Grünenthal, collaboration sits at the core of every partnership — and we are focused on diversifying our portfolio through collaborations that offer synergies with our infrastructure, commercial capabilities, and regulatory expertise.

In markets where we do not have our own footprint, we value working with those who bring deep market expertise, knowledge in the therapeutic areas of our products, and that help us gain insights into regions or therapeutic areas where we’re less active.

Ready to Collaborate? Let’s Talk.

If you are interested in partnering with us, we’d love to hear from you. Our teams attend a range of conferences and events throughout the year, expand the list to see where we will be, and how you can connect with us in person.

Meet us

Meet Grünenthal's Partnering / Contract Manufacturing Team at the following conferences:

BIO International

June 22-25,2026
San Diego Convention Center, USA
BIO International Convention | June 22-25 | San Diego

CPHI

October 6-8, 2026
Fiera Milano, Italy
CPHI Milan 2026: Shaping pharma's future

BIO Europe

Nov 9-11, 2026
Cologne (Köln), Germany

Jefferies Healthcare Conference

Nov 16-19, 2026
The Waldorf Hilton, London, UK
Global Healthcare Conference in London | Jefferies.com

Prefer to get in touch directly?

Use the form below to contact the relevant team based on your region and area of interest.

Want to learn more about our CMO offerings?

Visit the Grünenthal Pro website to explore our capabilities.

Get in contact

External Link